Toll-like receptor 2 signalling as a potential therapeutic target in gastric cancer

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1088634

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Stomach cancer is the fourth most deadly cancer in the world. Stomach cancer is closely linked with inflammation, and we have shown that a key inflammatory molecule, called toll-like receptor 2 (TLR2), can drive the development of stomach cancer. However, this occurs in a non-inflammatory manner. My research aims to understand how TLR2 is involved in the progression of stomach cancer, with the ultimate goal to find an early biomarker of disease, and to develop better therapies.

Funded Activity Details

Start Date: 01-01-2015

End Date: 01-01-2021

Funding Scheme: Early Career Fellowships

Funding Amount: $323,091.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Molecular Targets

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cancer immunology | cancer therapy | cytokine signalling | gastric cancer | innate immunity

Related Links